ARCHIVES

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 08 | February 21, 2003

Download PDF Visit The Full Archive

Related Articles

Letter: Cancer Centers Need Ingenuity To Continue Clinical Research

October 27, 1995

In Brief: FDA To Review Preclinical Testing, Phase I Protocols At Open Advisory Group Meeting

November 14, 1975

Patient Advocacy: Prostate Cancer Agenda Didn’t Include NCI Plans, Lausner Says

November 29, 1996

CTEP Deploys Website To Track Trial Activation

December 10, 2010

In congress: Sen. Harkin: “What Causes Cancer” If We Don’t Know The Cause, How Can We Get Into Prevention?

June 27, 1997

NIH advisors Review Intramural Program, Plan Spring Report

December 10, 1993